Cargando…
The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription
Short-acting β(2) agonists (SABAs) have been a mainstay of asthma treatment since the 1950s, and have been mainly recommended as-needed for symptom relief alongside daily inhaled corticosteroid (ICS)-based maintenance treatment for the past 30 years. However, patient adherence to regular ICS-based a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070225/ https://www.ncbi.nlm.nih.gov/pubmed/36715896 http://dx.doi.org/10.1007/s12325-022-02410-z |